| RS1060503666 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1060503667 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1060503669 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1060503670 |
NF2
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 2 |
| RS1060503671 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1060503672 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS1060503674 |
NF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 2 |
| RS1060503677 |
SLC35A2
|
Health Risk |
Conflicting classifications of pathogenicity |
SLC35A2-congenital disorder of glycosylation, Lung cancer |
| RS1060503688 |
RPS19
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS1060503690 |
BBS1
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 1 |
| RS1060503692 |
BBS4
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 4 |
| RS1060503696 |
KCNT1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1060503706 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1060503711 |
SDHA
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex II deficiency, nuclear type 1 |
| RS1060503726 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503727 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503728 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503731 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503732 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503733 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503735 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503737 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503739 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503743 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503744 |
BAP1
|
Health Risk |
Pathogenic |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503748 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, BAP1-related tumor predisposition syndrome |
| RS1060503750 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
BAP1-related tumor predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503751 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503752 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503753 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503757 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503759 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503762 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503763 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503764 |
SDHB
|
Health Risk |
Pathogenic |
Gastrointestinal stromal tumor, Pheochromocytoma |
| RS1060503767 |
SDHB
|
Health Risk |
Pathogenic |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1060503768 |
SDHB
|
Health Risk |
Conflicting classifications of pathogenicity |
Pheochromocytoma/paraganglioma syndrome 4, Gastrointestinal stromal tumor |
| RS1060503769 |
SDHD
|
Health Risk |
Pathogenic |
Pheochromocytoma, Cowden syndrome 3 |
| RS1060503770 |
SDHD
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cowden syndrome 3 |
| RS1060503773 |
SDHD
|
Health Risk |
Pathogenic/Likely pathogenic |
Pheochromocytoma, Pheochromocytoma/paraganglioma syndrome 1 |
| RS1060503780 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Malignant tumor of breast |
| RS1060503782 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503786 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Peutz-Jeghers syndrome |
| RS1060503787 |
STK11
|
Health Risk |
Conflicting classifications of pathogenicity |
Peutz-Jeghers syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503789 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1060503800 |
SBF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 4, Inborn genetic diseases |
| RS1060503831 |
GATA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Deafness-lymphedema-leukemia syndrome, Monocytopenia with susceptibility to infections |
| RS1060503834 |
KCNJ5
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1060503838 |
HCN4
|
Health Risk |
Conflicting classifications of pathogenicity |
Brugada syndrome 8, Brugada syndrome 8 |
| RS1060503839 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503841 |
PTEN
|
Health Risk |
Conflicting classifications of pathogenicity |
PTEN hamartoma tumor syndrome, Hereditary cancer-predisposing syndrome |
| RS1060503853 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Cardiomyopathy |
| RS1060503855 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS1060503861 |
CDKN1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Beckwith-Wiedemann syndrome, IMAGe syndrome |
| RS1060503869 |
CDKN1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia type 4, Hereditary cancer-predisposing syndrome |
| RS1060503901 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1060503905 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1060503909 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1060503918 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1060503922 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1060503924 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1060503941 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1060503946 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1060503950 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1060503989 |
BLM
|
Health Risk |
Pathogenic/Likely pathogenic |
Bloom syndrome, Bloom syndrome |
| RS1060503990 |
ZEB2
|
Health Risk |
Pathogenic |
Mowat-Wilson syndrome, Mowat-Wilson syndrome |
| RS1060503994 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome 2 |
| RS1060503999 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Colorectal cancer |
| RS1060504002 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1060504010 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1060504016 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1060504025 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504026 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504028 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile polyposis syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504029 |
SMAD4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Juvenile polyposis syndrome |
| RS1060504064 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504069 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504079 |
FH
|
Health Risk |
Conflicting classifications of pathogenicity |
Fumarase deficiency, Hereditary leiomyomatosis and renal cell cancer |
| RS1060504084 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1060504095 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1060504116 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1060504119 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1060504137 |
SCN8A
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1060504143 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1060504144 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Marfan syndrome |
| RS1060504147 |
SUFU
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Gorlin syndrome |
| RS1060504154 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac arrhythmia, ankyrin-B-related |
| RS1060504160 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome |
| RS1060504161 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 |
| RS1060504163 |
TP53
|
Health Risk |
Conflicting classifications of pathogenicity |
Li-Fraumeni syndrome, Li-Fraumeni syndrome 1 |
| RS1060504172 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Malignant tumor of breast |
| RS1060504181 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1060504182 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1060504184 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1060504185 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1060504190 |
BARD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Hereditary cancer-predisposing syndrome |
| RS1060504203 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1060504205 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1060504206 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1060504219 |
RECQL4
|
Health Risk |
Conflicting classifications of pathogenicity |
Baller-Gerold syndrome, Inborn genetic diseases |